CA2593572C - Systeme et procede d'administration de medicament dans les voies nasales - Google Patents
Systeme et procede d'administration de medicament dans les voies nasales Download PDFInfo
- Publication number
- CA2593572C CA2593572C CA002593572A CA2593572A CA2593572C CA 2593572 C CA2593572 C CA 2593572C CA 002593572 A CA002593572 A CA 002593572A CA 2593572 A CA2593572 A CA 2593572A CA 2593572 C CA2593572 C CA 2593572C
- Authority
- CA
- Canada
- Prior art keywords
- vial
- pump
- medicament
- nozzle
- piston
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000003814 drug Substances 0.000 title claims abstract description 126
- 238000000034 method Methods 0.000 title description 31
- 230000007246 mechanism Effects 0.000 claims abstract description 156
- 239000003570 air Substances 0.000 claims abstract description 38
- 238000004891 communication Methods 0.000 claims abstract description 27
- 239000012080 ambient air Substances 0.000 claims abstract description 13
- 230000000295 complement effect Effects 0.000 claims abstract description 12
- 239000000463 material Substances 0.000 claims description 37
- 238000011049 filling Methods 0.000 claims description 25
- 238000007789 sealing Methods 0.000 claims description 23
- 239000007788 liquid Substances 0.000 description 122
- 239000012530 fluid Substances 0.000 description 112
- 238000002788 crimping Methods 0.000 description 63
- 230000033001 locomotion Effects 0.000 description 50
- 230000006835 compression Effects 0.000 description 29
- 238000007906 compression Methods 0.000 description 29
- 239000000443 aerosol Substances 0.000 description 19
- 230000008901 benefit Effects 0.000 description 19
- 230000008569 process Effects 0.000 description 16
- 238000006073 displacement reaction Methods 0.000 description 15
- 230000009471 action Effects 0.000 description 14
- 230000006870 function Effects 0.000 description 13
- 239000007921 spray Substances 0.000 description 12
- 238000011109 contamination Methods 0.000 description 10
- 239000013013 elastic material Substances 0.000 description 10
- 230000002829 reductive effect Effects 0.000 description 10
- 230000007423 decrease Effects 0.000 description 9
- 239000012528 membrane Substances 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- 239000003755 preservative agent Substances 0.000 description 7
- -1 e.g. Substances 0.000 description 6
- 238000003780 insertion Methods 0.000 description 6
- 230000037431 insertion Effects 0.000 description 6
- 238000009472 formulation Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- KAKZBPTYRLMSJV-UHFFFAOYSA-N Butadiene Chemical compound C=CC=C KAKZBPTYRLMSJV-UHFFFAOYSA-N 0.000 description 4
- 229920002633 Kraton (polymer) Polymers 0.000 description 4
- 239000004479 aerosol dispenser Substances 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 239000012611 container material Substances 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 230000003993 interaction Effects 0.000 description 4
- 239000004033 plastic Substances 0.000 description 4
- 229920003023 plastic Polymers 0.000 description 4
- 230000004913 activation Effects 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 239000000356 contaminant Substances 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- 229920002635 polyurethane Polymers 0.000 description 3
- 239000004814 polyurethane Substances 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 239000003380 propellant Substances 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 230000002441 reversible effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 238000012371 Aseptic Filling Methods 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 230000000881 depressing effect Effects 0.000 description 2
- 230000005489 elastic deformation Effects 0.000 description 2
- 229920001971 elastomer Polymers 0.000 description 2
- 238000005429 filling process Methods 0.000 description 2
- 229920002457 flexible plastic Polymers 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001195 polyisoprene Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000284 resting effect Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 229920002725 thermoplastic elastomer Polymers 0.000 description 2
- 210000003813 thumb Anatomy 0.000 description 2
- 238000012546 transfer Methods 0.000 description 2
- YSGQGNQWBLYHPE-CFUSNLFHSA-N (7r,8r,9s,10r,13s,14s,17s)-17-hydroxy-7,13-dimethyl-2,6,7,8,9,10,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-one Chemical compound C1C[C@]2(C)[C@@H](O)CC[C@H]2[C@@H]2[C@H](C)CC3=CC(=O)CC[C@@H]3[C@H]21 YSGQGNQWBLYHPE-CFUSNLFHSA-N 0.000 description 1
- 206010027654 Allergic conditions Diseases 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000000806 elastomer Substances 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 231100000719 pollutant Toxicity 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 229920003031 santoprene Polymers 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
Landscapes
- Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/460,050 US6302101B1 (en) | 1999-12-14 | 1999-12-14 | System and method for application of medicament into the nasal passage |
| US09/460,050 | 1999-12-14 | ||
| CA002394559A CA2394559C (fr) | 1999-12-14 | 2000-12-11 | Systeme et procede d'administration de medicament dans les voies nasales |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002394559A Division CA2394559C (fr) | 1999-12-14 | 2000-12-11 | Systeme et procede d'administration de medicament dans les voies nasales |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2593572A1 CA2593572A1 (fr) | 2001-06-21 |
| CA2593572C true CA2593572C (fr) | 2009-11-24 |
Family
ID=38520972
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002593572A Expired - Fee Related CA2593572C (fr) | 1999-12-14 | 2000-12-11 | Systeme et procede d'administration de medicament dans les voies nasales |
| CA2592954A Expired - Fee Related CA2592954C (fr) | 1999-12-14 | 2000-12-11 | Nouvelles methodes de synthese d'alfentanil, de sufentanil et de remifentanil |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2592954A Expired - Fee Related CA2592954C (fr) | 1999-12-14 | 2000-12-11 | Nouvelles methodes de synthese d'alfentanil, de sufentanil et de remifentanil |
Country Status (1)
| Country | Link |
|---|---|
| CA (2) | CA2593572C (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220184327A1 (en) * | 2019-05-07 | 2022-06-16 | Aobiome Llc | Devices for storage and delivery of nonpathogenic microorganisms |
-
2000
- 2000-12-11 CA CA002593572A patent/CA2593572C/fr not_active Expired - Fee Related
- 2000-12-11 CA CA2592954A patent/CA2592954C/fr not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CA2593572A1 (fr) | 2001-06-21 |
| CA2592954A1 (fr) | 2001-06-21 |
| CA2592954C (fr) | 2010-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2394559C (fr) | Systeme et procede d'administration de medicament dans les voies nasales | |
| US7331944B2 (en) | Ophthalmic dispenser and associated method | |
| AU701047B2 (en) | Fluid pump without dead volume | |
| US6761286B2 (en) | Fluid dispenser having a housing and flexible inner bladder | |
| CN100540148C (zh) | 封闭构件 | |
| JP2936485B2 (ja) | 液体又はクリーム状の物質を小滴状に分与する分与装置及びこの分与装置を包含する分与組立体 | |
| NZ283376A (en) | Push button metering device for dispensing constant unit doses | |
| AU2002239480A1 (en) | Fluid dispenser with bladder inside rigid vial | |
| CA2593572C (fr) | Systeme et procede d'administration de medicament dans les voies nasales | |
| WO2004037708A2 (fr) | Distributeur de fluide possedant un flacon rigide et une vessie interne souple | |
| CA2578803C (fr) | Distributeur de liquide a flacon rigide et a vessie interieure souple | |
| AU2005205786B2 (en) | Fluid Dispenser Having a One-Way Valve, Pump, Variable-Volume Storage Chamber, and a Needle Penetrable and Laser Resealable Portion | |
| AU2012200348B2 (en) | Fluid Dispenser Having a Housing and Flexible Inner Bladder |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |
Effective date: 20121211 |